medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2011, Number 2

<< Back Next >>

Rev Invest Clin 2011; 63 (2)

Cancer stem cells

Schwarz-Cruz-y-Celis Á, Meléndez-Zajgla J

Language: English
References: 46
Page: 179-186
PDF size: 283.58 Kb.


ABSTRACT

There are two hypotheses that explain tumor progression. The first one, the stochastic hypothesis, assumes that any cell within a tumor has the capacity to form and maintain the tumor mass. The second, the so-called hierarchical hypothesis, suggests the existence of a group of cells with a stem phenotype which, like in normal tissues, preserves tumors through a continuous production of progeny. These stem cells are in a particular niche, have a higher resistance to chemotherapy and radiotherapy, and are also capable of invading and migrating to other tissues. This review describes the cancer stem cells (CSCs), their function inside a tumor and the current knowledge about these cells.


REFERENCES

  1. Hanahan D, Weinberg RA. The Hallmarks of Cancer. Cell 2000; 100(1): 57-70.

  2. Marotta LL, Polyak K. Cancer stem cells: a model in the making. Curr Opin Genet Dev 2009; 19(1): 44-50.

  3. Costa FF, Le Blanc K, Brodin B. Concise Review: Cancer/ Testis Antigens, Stem Cells, and Cancer. Stem Cells 2007; 25(3): 707-11.

  4. Dick JE. Acute Myeloid Leukemia Stem Cells. Ann NY Acad Sci 2005; 1044: 1-5.

  5. Dontu G. Breast cancer stem cell markers-the rocky road to clinical applications. Breast Cancer Res 2008; 10(5): 110.

  6. Cheshier SH, Kalani MY, Lim M, et al. A Neurosurgeon’s Guide to Stem Cells, Cancer Stem Cells, and Brain Tumor Stem Cells. Neurosurg 2009; 65(2): 237-49.

  7. Dick JE. Breast cancer stem cells revealed. Proc Natl Acad Sci USA 2003; 100(7): 3547-9.

  8. Chumsri S, Phatak P, Edelman MJ, et al. Cancer Stem Cells and Individualized Therapy. Cancer Genomics Proteomics 2007; 4(3): 165-74.

  9. Ponti D, Costa A, Zaffaroni N, et al. Isolation and In vitro Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties. Cancer Res 2005; 65(13): 5506-11.

  10. Dalerba P, Dylla SJ, Park IK, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007; 104(24): 10158-63.

  11. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature 2004; 432(7015): 396-401.

  12. Charafe-Jauffret E, Ginestier C, Birnbaum D. Breast cancer stem cells: tools and models to rely on. BMC Cancer 2009; 9: 202.

  13. Liu R, Wang X, Chen GY, et al. The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer Cells. N Engl J Med 2007; 356(3): 217-26.

  14. Acevedo PA, Cortés MM. Células madre: generalidades, eventos biológicos y moleculares. Iatreia 2008; 21(3): 292-306.

  15. Yang ZF, Ho DW, Ng MN, et al. Significance of CD90+ Cancer Stem Cells in Human Liver. Cancer Cell 2008; 13(2): 153-66.

  16. Dean M, Fojo T, Bates S. Tumor stem cells and drug resistance. Nat Rev Cancer 2005; 5(4): 275-84.

  17. Ponnusamy MP, Batra SK. Ovarian Cancer: Emerging concept on cancer stem cells. J Ovarian Res 2008; 1(1): 4.

  18. Ashkenazi R, Gentry SN, Jackson TL. Pathways to tumorigenesis- modeling mutation acquisition in stem cells and their progeny. Neoplasia 2008; 10(11): 1170-82.

  19. Morrison SJ, Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 2006; 441(7097): 1068-74.

  20. Wang QZ, Lu YH, Jiang N, et al. The asymmetric division and tumorigenesis of stem cells. Chin J Cancer 2010; 29(3): 248-53.

  21. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature 2001; 414(6859): 105-11.

  22. Jordan CT, Guzman ML, Noble M. Cancer Stem Cells. N Engl J Med 2006; 355(12): 1253-61.

  23. Mayani H. Las Células Troncales Somáticas: Biología y Relevancia Clínica. En: Brena I (ed.). Células Troncales: Aspectos científicos-filosóficos y jurídicos. México D. F.: Universidad Nacional Autónoma de México; 2005, p. 1-24.

  24. Discher DE, Mooney DJ, Zandstra PW. Growth factors, matrices, and forces combine and control stem cells. Science 2009; 324(5935): 1673-7.

  25. Gao JX. Cancer stem cells: the lesson from pre-cancerous stem cells. J Cell Mol Med 2008; 12(1): 67-96.

  26. Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63(18): 5821-8.

  27. Singh SK, Clarke ID, Hide T, et al. Cancer stem cells in nervous system tumors. Oncogene 2004; 23(43): 7267-73.

  28. Bosch J, López-Picazo JM, García-Foncillas J, et al. Células madre y cáncer: dilucidando el origen de la célula madre tumoral. Rev Med Univ Navarra 2007; 51(2): 40-2.

  29. Polyak K, Hahn WC. Roots and stems: stem cells in cancer. Nat Med 2006; 12(3): 296-300.

  30. Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukemia after transplantation into SCID mice. Nature 1994; 367(6464): 645-8.

  31. Wicha MS. Cancer stem cell heterogeneity in hereditary breast cancer. Breast Cancer Res 2008; 10(2): 105.

  32. Al-Hajj M, Wicha MS, Benito-Hernández A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100(7): 3983-8.

  33. Charafe-Jauffret E, Ginestier C, Iovino F, et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 2009; 69(4): 1302-13.

  34. Clevers H. Stem Cells, asymmetric division and cancer. Nat Genet 2005; 37(10): 1027-8.

  35. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumors: accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8(10): 755-68.

  36. Dalerba P, Clarke MF. Cancer Stem Cells and Tumor Metastasis: First Steps into Uncharted Territory. Cell Stem Cell 2007; 1(3): 241-2.

  37. Sneddon JB, Werb Z. Location, location, location: The cancer stem cell niche. Cell Stem Cell 2007; 1(6): 607-11.

  38. Clarke MF, Fuller M. Stem Cells and Cancer: Two faces of Eve. Cell 2006; 124(6): 1111-15.

  39. Majeti R, Becker MW, Tian Q, et al. Dysregulated gene expression networks in human acute myelogenous leukemia stem cells. Proc Natl Acad Sci USA 2009; 106(9): 3396-401.

  40. Korkaya H, Wicha MS. HER-2, Notch, and Breast Cancer Stem Cells: Targeting an Axis of Evil. Clin Cancer Res 2009; 15(6): 1845-7.

  41. Clarke MF, Dick JE, Dirks PB, et al. Cancer Stem Cells-Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem Cells. Cancer Res 2006; 66(19): 9339-44.

  42. Meléndez J, Maldonado V. Células troncales cancerosas: ¿Clave para curar el cáncer? Ciencia y Desarrollo 2008; 34(224): 28-31.

  43. Klonisch T, Wiechec E, Hombach-Klonisch S, et al. Cancer stem cells markers in common cancers-therapeutic implications. Trends Mol Med 2008; 14(10): 450-60.

  44. Rosen JM, Jordan CT. The increasing complexity of the cancer stem cell paradigm. Science 2009; 324(5935): 1670-3.

  45. Dave B, Chang J. Treatment Resistance in Stem Cells and Breast Cancer. J Mammary Gland Biol Neoplasia 2009; 14(1): 79-82.

  46. Iwasaki H, Suda T. Cancer stem cells and their niche. Cancer Sci 2009; 100(7): 1166-72.




2020     |     www.medigraphic.com